Immunicum AB (publ) Announces Complete Topline Data Analysis from Phase II MERECA Trial
Keep reading
Immunicum AB (publ) Announces Positive Phase II MERECA Topline Results Including Complete Tumor Responses in Metastatic Renal Cell Carcinoma Patients
